Peer-reviewedCC BYPharmaceutics
Curcumin Nanodelivery for Tumor-Associated Macrophage Reprogramming and Immune-Checkpoint Sensitization: Engineering the Tumor Immune Microenvironment
- 1Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, , Philadelphia, PA 19140, USA
- 2Department of Chemical and Biological Engineering, , 1342 Seongnamdaero, Sujeong-gu, Seongnam-si 13120, Republic of Korea
Related
- Tumor Microenvironment-Triggered Dual-Prodrug Nanoplatform for Augmented Photodynamic Therapy: Self-Quenched Photosensitizer Activation and Nitric Oxide-Mediated Sensitization
- Fibromyalgia as a Persistent Multiscale Tissue State: A Temporal Matrix Hypothesis Linking Peripheral Microenvironment, Small Fibers, and Central Sensitization
- Redox Storm in the Tumor Microenvironment (ΤΜΕ): Multifaceted Redox Injury and Immunometabolic Reprogramming Induced by Immune Checkpoint Blockade in B16F10 Melanoma: An Ultrastructural Study of the Peritumoral Interface
- Host-Response Engineering in Regenerative Cardiology: Mechanistic Boundaries Between Remuscularization and Immune Reprogramming
- Engineering clinically actionable nanomedicine for cancer immunometabolic ecosystem reprogramming
BibTeX
@article{rana2026curcumin,
title = {{Curcumin Nanodelivery for Tumor-Associated Macrophage Reprogramming and Immune-Checkpoint Sensitization: Engineering the Tumor Immune Microenvironment}},
author = {Juie Nahushkumar Rana and Sohail Mumtaz},
journal = {Pharmaceutics},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13708596},
note = {CC BY},
}
RIS
TY - JOUR
TI - Curcumin Nanodelivery for Tumor-Associated Macrophage Reprogramming and Immune-Checkpoint Sensitization: Engineering the Tumor Immune Microenvironment
AU - Juie Nahushkumar Rana
AU - Sohail Mumtaz
PY - 2026
DA - 2026/10/01
JO - Pharmaceutics
UR - https://europepmc.org/article/PMC/PMC13708596
SN - 1999-4923
ER -